European Journal of Medicinal Chemistry p. 782 - 801 (2019)
Update date:2022-08-28
Topics:
Wang, Jubo
Li, Tinghan
Zhao, Tengteng
Wu, Tizhi
Liu, Chuang
Ding, Hong
Li, Zhiyu
Bian, Jinlei
Wogonin, a natural product isolated from the plant Scutellaria baicalensis, has been shown to be a potent and selective inhibitor of CDK9. With the purpose of investigating the activity and selectivity of this chemical scaffold, several series of wogonin derivatives were prepared and screened for CDK9 inhibition and cellular antiproliferative activity. Among these compounds, the drug-like compound 51 showed potent activity against CDK9 (IC50 = 19.9 nM) and MV4-11 cell growth (IC50 = 20 nM). In addition, compound 51 showed much improved physicochemical properties, such as water solubility, compared with the parent compound wogonin. The follow-up studies showed that the compound 51 is selective toward CDK9-overexpressing cancer cells over normal cells. Preliminary mechanism studies on the anticancer effect indicated that 51 inhibited the proliferation of MV4-11 cells via caspase-dependent apoptosis. In addition, highlighted compound 51 showed significant antitumor activity in mouse acute myeloid leukemia (AML) models without producing apparent toxic effects in vivo, which gave us a new tool for further investigation of CDK9-targeted inhibitor as a potential antitumor drug especially for AML.
View Morewebsite:http://www.maisonchem.com.cn
Contact:0086-311-83833777
Address:Leitou industrial district, xinji, shijiazhuang city, hebei province,
Jiangxi Lixin Pharmaceutical Co.,Ltd.
Contact:0798-8337222; 18979813215
Address:Jiangxi City, Jindezheng Province
Hangzhou Pharma & Chem Co.,Ltd.
Contact:+86-571-87040515
Address:No,139Qingchun Rd
Qingdao S. H. Huanyu Imp. & Exp. Co., Ltd.
Contact:86-532-88250866
Address:Room 615, World Trade Centre Building B, Hongkong Middle Roda 6#, Qingdao, Shandong, China
Zhejiang Sucon Silicone Co.,Ltd
Contact:+86-575-88046692
Address:Qisheng Rd., Paojiang Industrial Zone, Shaoxing, Zhejiang, China.
Doi:10.1111/j.1751-1097.2007.00268.x
(2008)Doi:10.1246/bcsj.72.2345
(1999)Doi:10.1039/c39920000059
(1992)Doi:10.1016/0040-4039(94)88224-X
(1994)Doi:10.1246/cl.1985.1009
(1985)Doi:10.1002/mrc.1509
(2005)